Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 558

1.

The protean neurologic manifestations of varicella-zoster virus infection.

Nagel MA, Gilden DH.

Cleve Clin J Med. 2007 Jul;74(7):489-94, 496, 498-9 passim. Review.

PMID:
17682626
2.

[Herpes zoster in old adults].

Lang PO, Belmin J, Michel JP.

Presse Med. 2009 Apr;38(4):571-83. doi: 10.1016/j.lpm.2008.05.019. Epub 2008 Nov 22. Review. French.

PMID:
19028069
3.

The variegate neurological manifestations of varicella zoster virus infection.

Gilden D, Nagel MA, Cohrs RJ, Mahalingam R.

Curr Neurol Neurosci Rep. 2013 Sep;13(9):374. doi: 10.1007/s11910-013-0374-z. Review.

4.

[Reactivation of herpes zoster infection by varicella-zoster virus].

Cvjetković D, Jovanović J, Hrnjaković-Cvjetković I, Brkić S, Bogdanović M.

Med Pregl. 1999 Mar-May;52(3-5):125-8. Review. Croatian.

PMID:
10518396
5.

Herpes zoster guideline of the German Dermatology Society (DDG).

Gross G, Schöfer H, Wassilew S, Friese K, Timm A, Guthoff R, Pau HW, Malin JP, Wutzler P, Doerr HW.

J Clin Virol. 2003 Apr;26(3):277-89; discussion 291-3.

PMID:
12637076
6.

Management of herpes zoster (shingles) and postherpetic neuralgia.

Stankus SJ, Dlugopolski M, Packer D.

Am Fam Physician. 2000 Apr 15;61(8):2437-44, 2447-8. Review.

7.

[Herpes zoster and post-herpetic neuralgia in older adults].

Lang PO, Zarate-Lagunes M, Pautex S.

Rev Med Suisse. 2008 Nov 5;4(178):2398-402, 2404. Review. French.

PMID:
19051627
8.

Post-herpetic neuralgia in older adults: evidence-based approaches to clinical management.

Christo PJ, Hobelmann G, Maine DN.

Drugs Aging. 2007;24(1):1-19. Review.

PMID:
17233544
9.

Prevention of shingles by varicella zoster virus vaccination.

Holodniy M.

Expert Rev Vaccines. 2006 Aug;5(4):431-43. Review.

PMID:
16989624
10.

Varicella zoster virus infection: clinical features, molecular pathogenesis of disease, and latency.

Mueller NH, Gilden DH, Cohrs RJ, Mahalingam R, Nagel MA.

Neurol Clin. 2008 Aug;26(3):675-97, viii. doi: 10.1016/j.ncl.2008.03.011. Review.

11.

Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.

Breuer J, Whitley R.

Herpes. 2007 Sep;14 Suppl 2:25-9. Erratum in: Herpes. 2007 Dec;14(3):74.

PMID:
17939892
12.

Varicella virus-mononuclear cell interaction.

White TM, Gilden DH.

Adv Virus Res. 2003;62:1-17. Review.

PMID:
14719363
13.

Varicella zoster virus latency, neurological disease and experimental models: an update.

Cohrs RJ, Gilden DH, Mahalingam R.

Front Biosci. 2004 Jan 1;9:751-62. Review.

PMID:
14766405
14.

A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.

Holcomb K, Weinberg JM.

J Drugs Dermatol. 2006 Oct;5(9):863-6. Review.

PMID:
17039651
15.

Infections of the nervous system caused by varicella-zoster virus: a review.

Echevarría JM, Casas I, Martínez-Martín P.

Intervirology. 1997;40(2-3):72-84. Review.

PMID:
9450225
16.

Neurological disease produced by varicella zoster virus reactivation without rash.

Gilden D, Cohrs RJ, Mahalingam R, Nagel MA.

Curr Top Microbiol Immunol. 2010;342:243-53. doi: 10.1007/82_2009_3. Review.

17.

Varicella-zoster virus reactivation without rash.

Gilden DH, Dueland AN, Devlin ME, Mahalingam R, Cohrs R.

J Infect Dis. 1992 Aug;166 Suppl 1:S30-4. Review.

PMID:
1320648
18.

Herpes zoster in older adults.

Cadogan MP.

J Gerontol Nurs. 2010 Mar;36(3):10-4. doi: 10.3928/00989134-20100218-01.

PMID:
20302254
19.

Neurological complications of varicella zoster virus reactivation.

Nagel MA, Gilden D.

Curr Opin Neurol. 2014 Jun;27(3):356-60. doi: 10.1097/WCO.0000000000000092. Review.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk